Bazex paraneoplastic acrokeratosis: a case report and response to Tigason.
A clinically typical case of Bazex acrokeratosis neoplastica is presented. This case is unusual in that the syndrome developed two years after a neoplasm was diagnosed. Almost complete clinical clearance was obtained with oral Tigason, making it the first recorded case to improve without removal of the underlying neoplasm.
D002294:Carcinoma, Squamous Cell / Q000556:secondary; D005050:Etretinate / Q000627:therapeutic use*; D005121:Extremities; D006258:Head and Neck Neoplasms / Q000556:secondary; D006801:Humans; D007642:Keratosis / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009382:Neoplasms, Unknown Primary; D010257:Paraneoplastic Syndromes / Q000188:drug therapy* / Q000473:pathology
D005050:Etretinate